Author: Barash, Ayelet; Machluf, Yossy; Ariel, Ilana; Dekel, Yaron
Title: The Pursuit of COVID-19 Biomarkers: Putting the Spotlight on ACE2 and TMPRSS2 Regulatory Sequences Cord-id: fycp2lx7 Document date: 2020_10_30
ID: fycp2lx7
Snippet: Diverse populations worldwide are differentially affected by coronavirus disease 2019 (COVID-19). While socioeconomic background has been studied extensively, little is known about the genetic variation underlying this phenomenon. This study is aimed at examining the genetic basis behind the great discrepancies among diverse ethnic groups in terms of COVID-19 susceptibility for viral infection, disease prognosis, and mortality. To this end, in silico analysis of single-nucleotide polymorphisms (
Document: Diverse populations worldwide are differentially affected by coronavirus disease 2019 (COVID-19). While socioeconomic background has been studied extensively, little is known about the genetic variation underlying this phenomenon. This study is aimed at examining the genetic basis behind the great discrepancies among diverse ethnic groups in terms of COVID-19 susceptibility for viral infection, disease prognosis, and mortality. To this end, in silico analysis of single-nucleotide polymorphisms (SNPs) within regulatory sequences of the human angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2)—the virus's gateway to host cells—and their plausible implications on expression levels was conducted. We provide indication that the variation in the human ACE2 and TMPRSS2 regulatory sequences is likely to be involved in and contribute to this phenomenon. SNPs that are abundant in the more susceptible populations introduce binding sites (BSs) for transcription factors or they may invalidate BSs for transcription repressor—both may enhance target gene (ACE2 or TMPRSS2) expression in the relevant target tissues. SNPs that are abundant in the more resistant populations may invalidate BSs for a transcriptional repressor or they may introduce BSs for a transcriptional repressor or initiator of mRNA degradation, which may reduce target gene expression levels. This aspect, when added to the socioeconomic factors, can be a cause for the divergent prevalence of the disease and the different mortality rates within diverse populations. This demonstration may call for a shift in the paradigm of searching for COVID-19 biomarkers, such that SNPs within regulatory sequences should be of high importance.
Search related documents:
Co phrase search for related documents- acute phase and liver lung: 1, 2, 3, 4
- acute phase and low expression: 1, 2, 3
- acute phase and low extent: 1
- acute phase and low infection: 1, 2, 3, 4, 5
- acute phase and lung kidney: 1, 2, 3, 4, 5
- acute phase and lymphoid tissue: 1, 2
- acute phase response and liver lung: 1
- acute phase response and low infection: 1
- acute phase response and lung kidney: 1
- adipose tissue and liver lung: 1, 2, 3, 4, 5, 6, 7
- adipose tissue and low expression: 1, 2, 3
- adipose tissue and lung kidney: 1, 2, 3
- adipose tissue and lymphoid tissue: 1, 2
- liver lung and low expression: 1, 2, 3, 4, 5
- liver lung and low infection: 1, 2, 3
- liver lung and lung kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77
- liver lung and lung kidney urinary bladder: 1
- low expression and lung kidney: 1, 2, 3, 4, 5, 6, 7, 8
- low expression and lymphoid tissue: 1, 2
Co phrase search for related documents, hyperlinks ordered by date